Download full-text PDF

Source
http://dx.doi.org/10.1136/heartjnl-2023-323787DOI Listing

Publication Analysis

Top Keywords

dyspnoea dizziness
4
dizziness dysrhythmia
4
dysrhythmia middle-aged
4
middle-aged patient
4
dyspnoea
1
dysrhythmia
1
middle-aged
1
patient
1

Similar Publications

Scimitar syndrome is a rare congenital cardiopulmonary condition characterized by an anomalous pulmonary venous return from the right lung to the inferior vena cava (IVC). Most patients are diagnosed during infancy. Incomplete scimitar syndrome refers to a variant, where only a portion of the right lung drains abnormally into the IVC without associated cardiac defects.

View Article and Find Full Text PDF

Multi-dimensional outcomes following extracorporeal cardiopulmonary resuscitation.

Resusc Plus

March 2025

Department of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charité (DHZC), Campus Benjamin Franklin, Berlin, Germany.

Background: Recent trials suggested that extracorporeal cardio-pulmonary resuscitation (ECPR) with veno-arterial extracorporeal membrane oxygenation (VA-ECMO) or "ECMELLA" (VA-ECMO plus Impella®) may improve short-term survival and neurological outcomes in selected patients with refractory cardiac arrest. However, long-term effects on cardiac, cognitive, physical and psychological health need further study. A multidisciplinary post-ECPR outpatient care program was developed at two centers, involving cardiologists, neurologists, psychologists and medical sociologists to assess seven key health dimensions.

View Article and Find Full Text PDF

: This study investigated the prevalence of functional impairments and the effects of long COVID on long-term functional impairments in patients with severe COVID-19. : We conducted a nationwide multicenter cohort study in collaboration with nine hospitals, collecting data using self-administered questionnaires from participants aged 20 years or older who were diagnosed with COVID-19, admitted to the intensive care unit (ICU) between April 2021 and September 2021, and discharged alive. Questionnaires regarding daily life, sequela, and functional impairments were mailed to patients in August 2022.

View Article and Find Full Text PDF

Safety assessment of rosuvastatin-fenofibrate combination in the treatment of hyperlipidemia based on FDA's adverse event reporting system database.

Front Pharmacol

February 2025

Department of Pharmacy, The Fourth Affiliated Hospital of School of Medicine, International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, Zhejiang, China.

Background: With the improvement of living standards, an increasing number of patients are presenting with mixed hyperlipidemia. In addition to cholesterol reduction, it is imperative to lower triglyceride levels. The combination of statin and fibrate for reducing lipid levels has commonly been applied in clinical therapy.

View Article and Find Full Text PDF

Presentation of Asymptomatic Ebstein's Anomaly: A Case Report.

Cureus

January 2025

Department of Cardiology, Southern Medical Group, Tallahassee, USA.

This report describes the case of a 58-year-old man with Ebstein's anomaly (EA) who remained asymptomatic until 55 years of age when he began experiencing acute dyspnea, palpitations, dizziness, and fatigue during exercise. Patients with EA have an increased risk for arrhythmia, right-sided heart failure, and sudden cardiac arrest. This case report highlights the late-onset complications of EA in a previously asymptomatic adult.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!